FINGER ALISON CECILY 4

4 · ADMA BIOLOGICS, INC. · Filed Feb 11, 2026

AI-generated summary of this filing

Updated Feb 12, 2026

ADMA BIOLOGICS Director Alison Finger Receives RSU Awards

What Happened

Alison Cecily Finger, a director of ADMA BIOLOGICS, INC. (ADMA), received two awards on Feb 9, 2026: 10,690 restricted stock units (RSUs) and 17,730 derivative units, both reported at $0 (total 28,420 units). No cash was paid — these are equity awards/compensation, not open-market purchases or sales.
The 10,690 RSUs vest in two equal installments at the six- and 12-month anniversaries of the grant (fully vested on Feb 9, 2027), per the filing footnotes.

Key Details

Transaction date: Feb 9, 2026; Form 4 filed Feb 11, 2026 (appears timely — Form 4 is generally due within two business days).
Reported amounts/prices: 10,690 RSUs @ $0.00 (acquired); 17,730 derivative units @ $0.00 (acquired). Total reported units = 28,420.
Shares/holdings after transaction (per footnote): the reporting person beneficially owned, as of the transaction date, 29,484 shares of common stock plus unvested RSUs (10,690 from this grant and 5,445 remaining from a prior grant), totaling 45,619 shares/RSU-equivalents.
Vesting/footnotes: F1 describes the 10,690 RSUs vesting in two equal installments at 6 and 12 months; F2 enumerates current holdings (see above). No 10b5-1 sales, tax-withholding, or option exercises were reported in this filing.

Context

RSUs and derivative awards represent the right to receive shares in the future subject to vesting and continued service; they are common compensation for executives and directors. These grants are not immediate purchases (which some investors view as a stronger bullish signal).
Because this is an award/compensation event, it should be interpreted as part of governance/compensation activity rather than a direct insider market bet.

Form 4

Period: 2026-02-09

Director

Transactions

Award
Common Stock
[F1][F2]
2026-02-09+10,690→ 45,619 total
Award
Stock Option (Right to Buy)
[F3]
2026-02-09+17,730→ 17,730 total
Exercise: $16.37Exp: 2036-02-09→ Common Stock (17,730 underlying)

Footnotes (3)

[F1]These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as of the applicable vesting date.
[F2]Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026, which will fully vest on February 9, 2027, subject to the Reporting Person's continued service as of such vesting date; (ii) 5,445 RSUs out of 10,889 RSUs granted on February 19, 2025, which will vest fully on February 19, 2026, subject to the Reporting Person's continued service as of such vesting date; and (iii) 29,484 shares of common stock owned by the Reporting Person.
[F3]These options vest in twelve equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.

Signature

/s/ Alison C. Finger, by Michael A. Goldstein as Attorney-in-fact|2026-02-11

1 file